Johnson & JohnsonvsViemed Healthcare

JNJ and VMD stock compared: price, dividend, valuation and results, from SEC filings.

VMD

Viemed Healthcare, Inc.

$8.94

Value $345M

-1.43%
VMD's page

Johnson & Johnson (JNJ) has a market value of $667B and Viemed Healthcare (VMD) $345M. Over the last year, with dividends, JNJ moved +41.7% and VMD +42.1%. The P/E is 41.4 for JNJ and 22.1 for VMD. Dividend yield: JNJ 1.91%, VMD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$667B

    VMD$345M

    JNJ is 1,932 times VMD

  • Revenue, 12 months

    JNJ$99.3B

    VMD$310M

    JNJ is 320 times VMD

  • Net income, 12 months

    JNJ$16.1B

    VMD$16M

    JNJ is 1,030 times VMD

  • Operating margin

    JNJ–

    VMD7.8%

  • ROIC

    JNJ12.4%

    VMD11.1%

    1.3 points apart

  • P/E

    JNJ41.4

    VMD22.1

    JNJ is 1.9 times VMD

  • Dividend yield

    JNJ1.9%

    VMD0.0%

    1.9 points apart

  • 5-year return

    JNJ+94.8%

    VMD+60.8%

    34.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+94.8%

VMD+60.8%

10015020020222023202420252026
Returns by period
PeriodJNJWith dividendsVMDWith dividends
1 year since November 17, 2025+41.7%Price +38.6%+42.1%Price +42.1%
3 years since November 17, 2023+101.1%+26.2% a yearPrice +84.7%+16.6%+5.2% a yearPrice +16.6%
5 years since November 17, 2021+94.8%+14.3% a yearPrice +69.4%+60.8%+10.0% a yearPrice +60.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonVMDViemed Healthcare

Valuation

JNJVMD
Valuation
Price$276.69$8.94
Market value$667B$345M
Enterprise value (EV)$694B$340M
P/E41.422.1
P/E, 5-year median21.928.6
P/B8.22.3
EV/EBIT39.114.1
Free cash flow yield3.1%6.2%

Results and growth

JNJVMD
Results and growth
Revenue, 12 months$99.3B$310M
Net income, 12 months$16.1B$16M
Free cash flow, 12 months$20.6B$21M
Earnings per share, 12 months$6.59$0.38
Revenue growth, year on year6.1%20.5%
Revenue growth a year, past+2.7%over 5 years+15.5%over 5 years
EPS growth a year, past+14.9%over 5 years-13.9%over 5 years

Margins and returns on capital

JNJVMD
Margins and returns on capital
Gross margin67.6%57.4%
Operating margin–7.8%
Net margin16.2%5.0%
ROIC12.4%11.1%
ROE19.7%11.0%

Balance sheet

JNJVMD
Balance sheet
Cash$17.2B$9.7M
Total debt$44.7B$9.3M
Net debt / EBITDA1.1-0.1
Interest cover18.0×–

Dividends and buybacks

JNJVMD
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%3.8%
Shareholder yield2.8%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or VMD

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Viemed Healthcare?

By market value, Johnson & Johnson ($667B) is about 1,932.2 times Viemed Healthcare ($345M), at today's prices.

How did JNJ and VMD stock do over the last 5 years?

Since November 17, 2021, JNJ's price moved +69.4% and VMD's +60.8%. With dividends: JNJ +94.8% (+14.3% a year), VMD +60.8% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or VMD?

The dividend yield at today's price is 1.91% for Johnson & Johnson and none for Viemed Healthcare. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and VMD?

At today's price, the P/E is 41.4 for JNJ and 22.1 for VMD. The median of the last five years was 21.9 and 28.6, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Viemed Healthcare?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 5.0% for Viemed Healthcare, and the operating margin – and 7.8%. Revenue was $99.3B and $310M.

Which is the better investment, Johnson & Johnson or Viemed Healthcare?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.